Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In other words, you don't understand the industry and don't care to understand. I'm not a chart reader. I'm a value investor. I will make some really good money on RNVA. I always do when I spot value day traders overlook. I owe no one an apology.
When you can define CAH and explain how it is affecting (or not affecting) RNVA earnings, I'll take your comments under advisement.
When you can define CAH and explain how it is affecting (or not affecting) RNVA earnings, I'll take your comments under advisement.
We should see money coming back into the market after a debt ceiling deal. As far as the OTC market goes, RNVA stands to be one of the stocks most affected. As long as CAH funds are secure, so are RNVA earnings. Day traders still don't get what's happening here. Long term investors will initiate the next RNVA run.
Current data - $805,560 Q1 earnings.
Off exchange. Bets on RS.
https://stockdaymedia.com/rennova-health-inc-rnva/#top - Q1 confirmed the DD in this article. Will see health care sector investment $$$ move to RNVA.
Out of the 000s on valuation. Pennies on growth and speculation.
Q1 earnings x 4= P/E of .93. Flatline projection.
You can track the same short interest data on finra.org too. It's reputable.
They took care of accounts payable with Q1 earnings. Would you have rather seen more shares issued? Otherwise, you are agreeing that the CEO can now turn to improving the company's financial structure. Draw your own trend projections, but flatline looks awfully good. It's the opposite of dilution now. Give the CEO some credit due.
Markets holding back some just in case the debt ceiling drama queens in congress F everything up.
800k = 8 billion shares at .0001. The CEO brought accounts current (instead of diluting) with a nice cash cushion at the end of the quarter. Now the company can turn earnings toward the financial structure with Sabby already willing to take a major haircut at .00014. THE thing to follow now will be how the CEO balances two options - growing into the current share structure and/or share buybacks. We know part of the plan is to utilize the Big South Fork Medical Center is part of the plan, leveraging an existing asset. At 800k a quarter and growing all sorts of MA possibilities are opened. This is a pretty dynamic turnaround.
$805,560 Q1 earnings.
Bottom line on the P/L for Christ's sake. It's called profit.
"Net income (loss) available to common stockholders - $805,560" (Page 4!) That's the bottom line.
Most posts debunk misinformation from people who don't read earnings reports. That's what's comical.
Q1 2023. Didn't anybody read it?
That's Q4 last year. Read Q1 2023.
The Q1 P/L shows over 800k in profit.
OMG read the earnings report!
A profitable company in 000s is an anomaly for sure.
Fact, RNVA is now profitable. Silly to keep talking about dilution. Next thing we hear from the CEO will be about cash management and growth.
I have seen no pumping of RNVA whatsoever. Let me give you a hint. Posts on this board have almost nothing to do with the if and when a stock moves, especially 000s which breakout when a larger scale institutional investor and/or another commercial investment firm pulls the trigger on buys. That will happen with RNVA. The stock of profitable companies don't stay in the 000s very long. They just don't. 000s belong to shells, inactive companies, and companies reporting huge insurmountable losses.
How about a few billion shares in volume today?
Could be. Delta Stag operating, best I can tell. I made some nice money on SVTE around the time it went dark. Held a few shares, out of curiosity mostly, when it went CE. Playing with free money essentially. We'll see if some of these that went cold with the OTC rule changes have to deal with common shares in MA and conversion situations, or going private maybe.
IMO the CEO and BoD should authorize a stock buyback of shares available at .0001 as long as they are available. After all, the bear OTC market forced more dilution that should have been necessary. The company might as well turn that to its own advantage while it can.
Then it probably would not have ever sold down to .0001. Might have tested the 000s, but full support would have come in at .0007-.0009.
That's a perfectly reasonable short-term target. RNVA was undervalued last year based on net revenue. Now it is ridiculously undervalued based on net earnings. Lolo's prediction of .05 is in range mid-term. Long-term depends on company's growth plan and related events. I have never seen a stock more undervalued, and I have toyed with OTC stocks for 25 years.
RNVA's forward P/E ratio just projecting flat earnings through the rest of the year is .93 (less than 1 to 1). A minimum standard P/E ratio for a value stock of 10 to 1 ratio lifts the stock out of the 000s. Then project out the growth curve the company is on. What, 20-1, 30-1? Higher? A current price of .002-.003 would still be a modest valuation.
Which equals .0099 ps. With over $800,000 profit last quarter and growing, that's not unreasonable.
Up. Out of 000s at least. If the profit is sustainable, and I think it is, and continues to grow, and I think it will, it could make it back to pennies. Who knows about timing? I sat on one for four years at .0001, then it shot to .02 in a matter of days. All I know for sure is, I've never seen a 000 stock with earnings reports like RNVA. I had one (SVTE) swing to a profit for one quarter and ran to .0013 a few months later, just as the company decided to go dark. I see RNVA remaining current and SEC compliant long term though.
A stock runs when you least expect it. It's Murphy Law.
Bound to. The earnings reports prove RNVA does not belong in 000s. The OTC market is full of momentum traders who follow price movements on PR and MA rumors. I'm more interested in value. I've picked a few 000 winners by finding value the OTC market overlooked. I saw some value in DPLS held patents with the stock at .0001-.0002 for example, when the company had little revenue to show for them. The federal CAH designation was the overlooked value I saw in RNVA, and still do, but now the earnings reports are speaking for themselves. Value investors do go bottom fishing from time to time, they'll come along. Investors closer to the health care industry probably already have their eyes on the stock and the company.
That wouldn't surprise me. If the p/l is sustainable just at current levels, RNVA is a legitimate (cash cow) acquisition target now too. In the meantime, RNVA is ripe for some major value investment that may well involve some capital moving around within the health care industry. This is good stuff. Value rules.
Settling convertible debt. Profit cures many ills.
An SEC compliant, current pink sheet stock of profitable company filing 8-Ks for every public utterance can hardly be considered a "scam." There are plenty of subpenny stocks I wouldn't argue if you called them scams. RNVA id definitely not one of those.